BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 17276888)

  • 1. Antibody response against neem leaf preparation recognizes carcinoembryonic antigen.
    Sarkar K; Bose A; Laskar S; Choudhuri SK; Dey S; Roychowdhury PK; Baral R
    Int Immunopharmacol; 2007 Mar; 7(3):306-12. PubMed ID: 17276888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A monoclonal antibody against neem leaf glycoprotein recognizes carcinoembryonic antigen (CEA) and restricts CEA expressing tumor growth.
    Das A; Barik S; Banerjee S; Bose A; Sarkar K; Biswas J; Baral R; Pal S
    J Immunother; 2014 Oct; 37(8):394-406. PubMed ID: 25198527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neem leaf glycoprotein helps to generate carcinoembryonic antigen specific anti-tumor immune responses utilizing macrophage-mediated antigen presentation.
    Sarkar K; Bose A; Chakraborty K; Haque E; Ghosh D; Goswami S; Chakraborty T; Laskar S; Baral R
    Vaccine; 2008 Aug; 26(34):4352-62. PubMed ID: 18590789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunostimulatory neem leaf preparation acts as an adjuvant to enhance the efficacy of poorly immunogenic B16 melanoma surface antigen vaccine.
    Baral R; Mandal I; Chattopadhyay U
    Int Immunopharmacol; 2005 Jul; 5(7-8):1343-52. PubMed ID: 15914339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neem leaf glycoprotein enhances carcinoembryonic antigen presentation of dendritic cells to T and B cells for induction of anti-tumor immunity by allowing generation of immune effector/memory response.
    Sarkar K; Goswami S; Roy S; Mallick A; Chakraborty K; Bose A; Baral R
    Int Immunopharmacol; 2010 Aug; 10(8):865-74. PubMed ID: 20472099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Murine carcinoma expressing carcinoembryonic antigen-like protein is restricted by antibody against neem leaf glycoprotein.
    Das A; Barik S; Bose A; Roy S; Biswas J; Baral R; Pal S
    Immunol Lett; 2014 Nov; 162(1 Pt A):132-9. PubMed ID: 25128841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neem (Azadirachta indica) leaf mediated immune activation causes prophylactic growth inhibition of murine Ehrlich carcinoma and B16 melanoma.
    Baral R; Chattopadhyay U
    Int Immunopharmacol; 2004 Mar; 4(3):355-66. PubMed ID: 15037213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neem leaf preparation enhances Th1 type immune response and anti-tumor immunity against breast tumor associated antigen.
    Mandal-Ghosh I; Chattopadhyay U; Baral R
    Cancer Immun; 2007 Mar; 7():8. PubMed ID: 17394284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of type 1 cytokines during neem leaf glycoprotein assisted carcinoembryonic antigen vaccination is associated with nitric oxide production.
    Sarkar K; Bose A; Haque E; Chakraborty K; Chakraborty T; Goswami S; Ghosh D; Baral R
    Int Immunopharmacol; 2009 Jun; 9(6):753-60. PubMed ID: 19285575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic anti-NLGP monoclonal antibody for carcinoembryonic antigen expressing tumors is nontoxic to Swiss and BALB/c mice.
    Das A; Mondal B; Bose A; Biswas J; Baral R; Pal S
    Int Immunopharmacol; 2015 Sep; 28(1):785-93. PubMed ID: 26283593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization with mimotopes prevents growth of carcinoembryonic antigen positive tumors in BALB/c mice.
    Brämswig KH; Knittelfelder R; Gruber S; Untersmayr E; Riemer AB; Szalai K; Horvat R; Kammerer R; Zimmermann W; Zielinski CC; Scheiner O; Jensen-Jarolim E
    Clin Cancer Res; 2007 Nov; 13(21):6501-8. PubMed ID: 17975163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiidiotype antibodies in cancer patients receiving monoclonal antibody to carcinoembryonic antigen.
    Traub UC; DeJager RL; Primus FJ; Losman M; Goldenberg DM
    Cancer Res; 1988 Jul; 48(14):4002-6. PubMed ID: 3289737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen.
    Saha A; Chatterjee SK; Foon KA; Celis E; Bhattacharya-Chatterjee M
    Cancer Res; 2007 Mar; 67(6):2881-92. PubMed ID: 17363612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of immune sera against carcinoembryonic antigen (CEA).
    Balbierz H; Nikołajczuk M
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):231-2. PubMed ID: 373678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neem (Azadirachta indica) leaf preparation prevents leukocyte apoptosis mediated by cisplatin plus 5-fluorouracil treatment in Swiss mice.
    Ghosh D; Bose A; Haque E; Baral R
    Chemotherapy; 2009; 55(3):137-44. PubMed ID: 19346744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretreatment with neem (Azadirachta indica) leaf preparation in Swiss mice diminishes leukopenia and enhances the antitumor activity of cyclophosphamide.
    Ghosh D; Bose A; Haque E; Baral R
    Phytother Res; 2006 Sep; 20(9):814-8. PubMed ID: 16807877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody to carcinoembryonic antigen in hamsters bearing GW-39 human tumors.
    Primus FJ; Wang RH; Cohen E; Hansen HJ; Goldenberg DM
    Cancer Res; 1976 Jul; 36(7 PT 1):2176-81. PubMed ID: 819127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of chimpanzee antiserum to human carcinoembryonic antigen.
    Haagensen DE; Metzgar RS; Sawlivich W; Swenson B; Davis S; Newman E; Zamcheck N; Wells SA; Hansen HJ
    Cancer Res; 1987 Nov; 47(21):5606-11. PubMed ID: 3664467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and specificities of antisera to the amino-terminal sequence of the carcinoembryonic antigen.
    Paul D; Flouret G; Tomita JT; Ranney K; Schenck J; Anderson B
    Cancer Res; 1981 Jun; 41(6):2315-21. PubMed ID: 7237430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Llama single-domain antibodies directed against nonconventional epitopes of tumor-associated carcinoembryonic antigen absent from nonspecific cross-reacting antigen.
    Behar G; Chames P; Teulon I; Cornillon A; Alshoukr F; Roquet F; Pugnière M; Teillaud JL; Gruaz-Guyon A; Pèlegrin A; Baty D
    FEBS J; 2009 Jul; 276(14):3881-93. PubMed ID: 19531051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.